Gilead Sciences Reveals a $15 Million RCUS Purchase

Arcus Biosciences $RCUS is ripping higher this morning, up around 8%, after Gilead Sciences just dropped nearly $15 million on the stock.

With today’s buy, Gilead seems to be doubling down on its bet on RCUS. Whether it’s a vote of confidence in Arcus or a sign of something bigger brewing, we’re paying attention to.

Here’s The Hot Corner, with data from February 20, 2025:

GAMCO Investors increased its stake in SuRo Capital Corp $SSSS from 0.90% to 5.30%, signaling growing confidence in the small-cap asset management firm.

Over in regional banks, Bank Leumi Le Israel picked up $9.35 million worth of Valley National Bancorp $VLY.

Meanwhile, Singapore’s sovereign wealth fund GIC Private Ltd boosted its position in BBB Foods $TBBB, taking its stake from 1.10% to 5.14%.